Bridgeway Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-65,000
| Closed | -$598K | – | 1411 |
|
|
2017
Q1 | $598K | Hold |
65,000
| – | – | 0.01% | 1000 |
|
|
2016
Q4 | $677K | Hold |
65,000
| – | – | 0.01% | 956 |
|
|
2016
Q3 | $588K | Hold |
65,000
| – | – | 0.01% | 1019 |
|
|
2016
Q2 | $486K | Sell |
65,000
-16,250
| -20% | -$122K | 0.01% | 1059 |
|
|
2016
Q1 | $732K | Sell |
81,250
-15,400
| -16% | -$139K | 0.01% | 900 |
|
|
2015
Q4 | $1.25M | Hold |
96,650
| – | – | 0.02% | 658 |
|
|
2015
Q3 | $934K | Hold |
96,650
| – | – | 0.02% | 772 |
|
|
2015
Q2 | $995K | Buy |
96,650
+65,000
| +205% | +$669K | 0.02% | 790 |
|
|
2015
Q1 | $352K | Buy |
+31,650
| New | +$352K | 0.01% | 1210 |
|